Forte Biosciences (FBRX) Interest & Investment Income (2016 - 2020)
Forte Biosciences (FBRX) reported Interest & Investment Income of $58000.0 for Q1 2020, down 89.28% year-over-year from $541000.0 in Q2 2019, and down 70.56% quarter-over-quarter from $197000.0 in Q4 2019.
Forte Biosciences (FBRX) Interest & Investment Income (2016 - 2020) Analysis & Trends
Forte Biosciences (FBRX) has 5 years of Interest & Investment Income data on file, last reported at $58000.0 in Q1 2020.
- Interest & Investment Income for Q1 2020 came in at $58000.0, down 89.28% year-over-year; the trailing twelve-month figure through Mar 2020 was $1.1 million (down 38.58% YoY), and the FY2019 annual result was $1.6 million, up 1.96% from the prior year.
- Interest & Investment Income fell to $58000.0 in Q1 2020 per FBRX's latest filing, from $197000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $541000.0 in Q1 2019 and troughed at $37000.0 in Q1 2017.
- A 5-year average of $233294.1 and a median of $214000.0 in 2017 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2018 and 2020: Interest & Investment Income surged 751.35% in 2018, then tumbled 89.28% in 2020.
- A 5-year view of Interest & Investment Income shows it stood at $45000.0 in 2016, then soared by 435.56% to $241000.0 in 2017, then soared by 85.48% to $447000.0 in 2018, then plunged by 55.93% to $197000.0 in 2019, then slumped by 70.56% to $58000.0 in 2020.
- Business Quant data shows FBRX's Interest & Investment Income at $58000.0 in Q1 2020, $197000.0 in Q4 2019, and $361000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 58,000.00 |
| Dec 31, 2019 | 197,000.00 |
| Sep 30, 2019 | 361,000.00 |
| Jun 30, 2019 | 465,000.00 |
| Mar 31, 2019 | 541,000.00 |
| Dec 31, 2018 | 447,000.00 |
| Sep 30, 2018 | 441,000.00 |
| Jun 30, 2018 | 331,000.00 |
| Mar 31, 2018 | 315,000.00 |
| Dec 31, 2017 | 241,000.00 |
| Sep 30, 2017 | 214,000.00 |
| Jun 30, 2017 | 103,000.00 |
| Mar 31, 2017 | 37,000.00 |
| Dec 31, 2016 | 45,000.00 |
| Sep 30, 2016 | 53,000.00 |
| Jun 30, 2016 | 56,000.00 |
| Mar 31, 2016 | 61,000.00 |